Complementary and alternative medicine for the treatment of major depressive disorder

Canadian Family Physician

Volumn 57, Issue 6, 2011, Pages 659-663

  Nahas, Richard ^a,c   Sheikh, Osmaan ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Seekers Centre for Integrative Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; FLUOXETINE; FOLIC ACID; FOLIC ACID DERIVATIVE; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; ICOSAPENTAENOIC ACID; LEVO METHYLFOLATE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OMEGA 3 FATTY ACID; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ACUPUNCTURE; ADJUVANT THERAPY; AEROBIC EXERCISE; ALTERNATIVE MEDICINE; ANXIETY; BECK DEPRESSION INVENTORY; BRAIN FUNCTION; CEREBROSPINAL FLUID; COGNITION; COLORECTAL CANCER; DEPRESSION; DNA POLYMORPHISM; DOPAMINE METABOLISM; DRUG COST; DRUG DOSE INCREASE; ELECTROACUPUNCTURE; EXERCISE; FOLIC ACID DEFICIENCY; GASTROINTESTINAL SYMPTOM; HIPPOCAMPUS; HUMAN; HYPERICUM PERFORATUM; INFECTION; KINESIOTHERAPY; MAJOR DEPRESSION; META ANALYSIS; METHYLATION; MONOTHERAPY; NAUSEA; NEUROPATHY; NEUROTRANSMITTER RELEASE; PNEUMOTHORAX; PUERPERAL DEPRESSION; RESISTANCE TRAINING; REVIEW; SEROTONIN METABOLISM; SEROTONIN SYNDROME; SEROTONIN UPTAKE; SIDE EFFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUPUNCTURE THERAPY; COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; EXERCISE THERAPY; FATTY ACIDS, OMEGA-3; FOLIC ACID; HUMANS; HYPERICUM; PHYTOTHERAPY; S-ADENOSYLMETHIONINE;

EID: 79959213140     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373(9665):746-58.
2. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358(3):252-60.
3. Freeman MP. Complementary and alternative medicine (CAM): considerations for the treatment of major depressive disorder. J Clin Psychiatry 2009;70(Suppl 5):4-6.
4. Shelton RC. St John's wort (Hypericum perforatum) in major depression. J Clin Psychiatry 2009;70(Suppl 5):23-7.
5. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev 2008;(4):CD000448.
6. Brattström A. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. Phytomedicine 2009;16(4):277-83. Epub 2009 Mar 18.
7. Izzo AA. Drug interactions with St. John's Wort: a review of clinical evidence. Int J Clin Pharmacol Ther 2004;42(3):139-48. (Pubitemid 38647590)
8. Di YM, Li CG, Xue CC, Zhou SF. Clinical drugs that interact with St. John's wort and implication in drug development. Curr Pharm Des 2004;14(17):1723-42.
9. Farah A. The role of L-methylfolate in depressive disorders. CNS Spectr 2009; 14(1 Suppl 2):2-7.
10. Morris DW, Trivedi M, Rush AJ. Folate and unipolar depression. J Altern Complement Med 2008;14(3):277-85. (Pubitemid 351519563)
11. Stahl SM. Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 2007;12(10):739-44. (Pubitemid 350072170)
12. Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord 1986;10(1):9-13. (Pubitemid 16109820)
13. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336(8712):392-5. (Pubitemid 20252436)
14. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 2000;60(2):121-30.
15. Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba Badiale M, et al. Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a doubleblind multicenter study. Aging (Milano) 1993;5(1):63-71. (Pubitemid 23117911)
16. Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Reports 2003;5(6):460-6. (Pubitemid 38899242)
17. Papakostas GI. Evidence for S-adenosyl-L-methionine (SAM-e) for treatment of major depressive disorder. J Clin Psychiatry 2009;70(Suppl 5):18-22.
18. Thomas CS, Bottiglieri T, Edeh J, Carney MW, Reynolds EH, Toone BK. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients. Int Clin Psychopharmacol 1987;2(2):97-102.
19. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53(12):1096-8.
20. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability or oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr 2002;76(Suppl):1172S-6S.
21. Fava M, Rosenbaum JF, Birnbaum R, Kelly K, Otto MW, MacLaughlin R. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients. Acta Psychiatr Scand 1992;86(1):42-5.
22. Smith CA, Hay PP, Macpherson H. Acupuncture for depression. Cochrane Database Syst Rev 2010;(1):CD004046.
23. Wang H, Qi H, Wang BS, Cui YY, Zhu L, Rong ZX, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 RCTs? J Affect Disord 2008;111(2-3):125-34. Epub 2008 Jun 11.
24. Samuels N, Gropp C, Singer SR, Oberbaum M. Acupuncture for psychiatric illness: a literature review. Behav Med 2008;34(2):55-64.
25. Song Y, Zhou D, Fan J, Luo H, Halbreich U. Effects of electroacupuncture and fluoxetine on the density of GTP-binding proteins in platelet membranes in patients with major depressive disorder. J Affect Disord 2007;98(3):253-7. Epub 2006 Aug 16. (Pubitemid 46149056)
26. Zhang WJ, Yang XB, Zhong BL. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. J Altern Complement Med 2009;15(8):837-44.
27. White A. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med 2004;22(3):122-33. (Pubitemid 40012600)
28. Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, et al. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur Neuropsychopharmacol 2010;20(1):1-17.
29. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev 2009;(3):CD004366.
30. Daley A, Jolly K, MacArthur C. The effectiveness of exercise in the management of post-natal depression: systematic review and meta-analysis. Fam Pract 2009;26(2):154-62. Epub 2009 Jan 6.
31. Tsang HW, Chan EP, Cheung WM. Effects of mindful and non-mindful exercises on people with depression: a systematic review. Br J Clin Psychol 2008;47(Pt 3):303-22. Epub 2008 Jan 31.
32. Singh NA, Clements KM, Fiatarone Singh MA. The efficacy of exercise as a longterm antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 2001;56(8):M497-504.
33. Meyer T, Broocks A. Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription. Sports Med 2000;30(4):269-79.
34. Freeman MP. Omega-3 fatty acids in major depressive disorder. J Clin Psychiatry 2009;70(Supp 5):7-11.
35. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007;68(7):1056-61.
36. Freeman MP. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot Essent Fatty Acids 2006;75(4-5):291-7. Epub 2006 Aug 22.
37. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003;23(2):e20-30. Erratum in: Arterioscler Thromb Vasc Biol 2003;23(2):e31.
38. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91(3):757-70. Epub 2010 Feb 3.
39. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 2007;99(6A):44C-6C. Epub 2009 Nov 29.